COM:ABIOMED
Abiomed
- Stock
Last Close
381.02
21/12 21:00
Market Cap
17.18B
Beta: -
Volume Today
15.70M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 14.44M - | 15.36M 6.39% | 21.76M 41.64% | 30.84M 41.73% | 42.57M 38.05% | 65.57M 54.04% | 85.52M 30.41% | 85.57M 0.07% | 87.52M 2.27% | |
average payables | 7.72M - | 9.07M 17.44% | 9.88M 9.02% | 15.00M 51.75% | 22.09M 47.28% | 27.88M 26.17% | 32.48M 16.52% | 33.81M 4.09% | 35.09M 3.80% | |
average receivables | 23.65M - | 28.09M 18.78% | 37.32M 32.86% | 48.44M 29.78% | 62.03M 28.07% | 80.41M 29.62% | 87.73M 9.10% | 90.91M 3.63% | 93.89M 3.28% | |
book value per share | 4.28 - | 7.18 67.65% | 8.74 21.77% | 10.46 19.66% | 15.62 49.36% | 20.86 33.58% | 23.58 13.05% | 29.46 24.91% | 33.08 12.30% | |
capex per share | -0.07 - | -0.13 81.90% | -0.37 189.94% | -1.17 214.96% | -1.27 8.51% | -0.98 22.56% | -0.97 0.59% | -1.18 21.41% | -0.79 33.46% | |
capex to depreciation | -1.10 - | -1.87 70.13% | -4.77 154.56% | -8.13 70.50% | -5.08 37.55% | -3.12 38.61% | -2.15 30.88% | -2.22 2.85% | -1.27 42.53% | |
capex to operating cash flow | -0.12 - | -0.12 1.86% | -0.20 69.76% | -0.44 115.26% | -0.29 33.75% | -0.17 39.86% | -0.14 19.91% | -0.19 39.13% | -0.13 35.54% | |
capex to revenue | -0.02 - | -0.02 49.83% | -0.05 110.47% | -0.11 138.79% | -0.09 16.90% | -0.06 39.21% | -0.05 8.49% | -0.06 20.36% | -0.03 44.97% | |
cash per share | 1.95 - | 3.25 66.81% | 5.02 54.71% | 5.32 5.85% | 8.20 54.27% | 10.95 33.44% | 9.81 10.42% | 12.93 31.84% | 16.69 29.09% | |
days of inventory on hand | 136.41 - | 153.27 12.36% | 193.58 26.30% | 180.52 6.74% | 185.88 2.97% | 228.02 22.67% | 217.32 4.69% | 182.74 15.91% | 182.31 0.23% | |
days payables outstanding | 75.75 - | 94.93 25.31% | 67.91 28.46% | 106.56 56.91% | 87.25 18.12% | 90.67 3.92% | 79.06 12.80% | 78.55 0.65% | 68.57 12.71% | |
days sales outstanding | 48.41 - | 50.44 4.19% | 47.43 5.97% | 44.31 6.58% | 43.04 2.86% | 43.08 0.09% | 36.74 14.70% | 41.85 13.90% | 32.05 23.41% | |
debt to assets | 0.01 - | 0.00 36.73% | 0.01 33.93% | 0.03 397.97% | 0.01 80.46% | 0.01 100.47% | 0.06 430.89% | 0.04 28.42% | ||
debt to equity | 0.01 - | 0.01 39.82% | 0.01 32.66% | 0.04 427.41% | 0.01 81.69% | 0.01 97.82% | 0.07 438.60% | 0.05 29.54% | ||
dividend yield | ||||||||||
earnings yield | 0.01 - | 0.04 444.65% | 0.01 75.61% | 0.01 0.98% | 0.01 9.31% | 0.02 137.83% | 0.03 49.08% | 0.02 49.36% | 0.01 42.15% | |
enterprise value | 1.00B - | 2.89B 187.64% | 3.95B 36.97% | 5.39B 36.37% | 12.81B 137.54% | 12.35B 3.53% | 6.37B 48.47% | 14.15B 122.35% | 14.92B 5.41% | |
enterprise value over ebitda | 90.90 - | 91.52 0.68% | 57.20 37.50% | 55.26 3.38% | 74.69 35.15% | 44.52 40.39% | 24.72 44.47% | 57.32 131.85% | 37.23 35.05% | |
ev to operating cash flow | 42.76 - | 66.67 55.92% | 51.48 22.79% | 46.83 9.03% | 66.50 42.02% | 48.98 26.35% | 20.21 58.73% | 51.55 155.02% | 52.28 1.42% | |
ev to sales | 5.46 - | 12.53 129.36% | 12.00 4.27% | 12.11 0.92% | 21.57 78.15% | 16.06 25.55% | 7.57 52.85% | 16.70 120.61% | 14.46 13.41% | |
free cash flow per share | 0.53 - | 0.94 78.14% | 1.45 54.57% | 1.50 3.24% | 3.10 106.88% | 4.64 49.75% | 6.00 29.35% | 4.90 18.28% | 5.49 12.10% | |
free cash flow yield | 0.02 - | 0.01 35.19% | 0.02 16.69% | 0.01 21.82% | 0.01 10.99% | 0.02 56.88% | 0.04 147.52% | 0.02 62.78% | 0.02 7.86% | |
graham net net | 1.65 - | 2.89 75.49% | 4.80 65.95% | 4.39 8.55% | 7.77 77.15% | 10.75 38.38% | 8.87 17.51% | 11.79 33.00% | 15.48 31.24% | |
graham number | 4.24 - | 21.25 401.00% | 13.33 37.28% | 16.84 26.32% | 29.88 77.43% | 52.03 74.14% | 48.83 6.15% | 57.54 17.85% | 47.28 17.83% | |
income quality | 3.19 - | 0.38 88.07% | 2.01 428.69% | 2.21 9.72% | 1.72 22.29% | 0.97 43.28% | 1.55 59.32% | 1.22 21.52% | 2.09 71.72% | |
intangibles to total assets | 0.18 - | 0.14 26.10% | 0.11 16.47% | 0.08 27.55% | 0.07 19.27% | 0.05 32.10% | 0.04 1.11% | 0.08 88.10% | 0.07 13.26% | |
interest coverage | 7.48 - | |||||||||
interest debt per share | 0.04 - | 0.04 0.89% | 0.06 61.55% | 0.38 531.08% | 0.10 72.66% | 0.27 164.25% | 1.66 508.88% | 1.46 11.99% | 1.10 25.04% | |
inventory turnover | 2.68 - | 2.38 11.00% | 1.89 20.82% | 2.02 7.23% | 1.96 2.88% | 1.60 18.48% | 1.68 4.92% | 2.00 18.93% | 2.00 0.23% | |
invested capital | 0.01 - | 0.01 39.82% | 0.01 32.66% | 0.04 427.41% | 0.01 81.69% | 0.01 97.82% | 0.07 438.60% | 0.05 29.54% | ||
market cap | 1.02B - | 2.91B 183.96% | 4.00B 37.58% | 5.41B 35.29% | 12.85B 137.34% | 12.47B 2.91% | 6.56B 47.43% | 14.39B 119.38% | 15.05B 4.63% | |
net current asset value | 80.91M - | 173.33M 114.22% | 233.24M 34.56% | 228.62M 1.98% | 397.42M 73.84% | 559.74M 40.84% | 484.87M 13.38% | 623.28M 28.55% | 806.41M 29.38% | |
net debt to ebitda | -1.89 - | -0.71 62.51% | -0.70 1.76% | -0.23 66.65% | -0.25 7.71% | -0.44 73.99% | -0.75 71.28% | -0.94 26.15% | -0.33 64.83% | |
net income per share | 0.19 - | 2.80 1,397.16% | 0.90 67.70% | 1.21 33.35% | 2.54 110.77% | 5.77 127.02% | 4.49 22.09% | 5.00 11.19% | 3.00 39.88% | |
operating cash flow per share | 0.60 - | 1.07 78.59% | 1.82 70.79% | 2.66 46.32% | 4.36 63.80% | 5.62 28.77% | 6.97 24.13% | 6.08 12.73% | 6.28 3.24% | |
payables turnover | 4.82 - | 3.84 20.20% | 5.37 39.78% | 3.43 36.27% | 4.18 22.14% | 4.03 3.77% | 4.62 14.68% | 4.65 0.66% | 5.32 14.56% | |
receivables turnover | 7.54 - | 7.24 4.03% | 7.70 6.35% | 8.24 7.04% | 8.48 2.95% | 8.47 0.09% | 9.93 17.24% | 8.72 12.20% | 11.39 30.57% | |
research and ddevelopement to revenue | 0.17 - | 0.16 6.59% | 0.15 3.33% | 0.15 1.27% | 0.13 14.93% | 0.12 4.17% | 0.12 3.35% | 0.14 22.44% | 0.16 10.13% | |
return on tangible assets | 0.04 - | 0.39 786.35% | 0.10 73.90% | 0.10 1.62% | 0.15 48.08% | 0.26 68.36% | 0.17 32.10% | 0.16 5.67% | 0.09 46.60% | |
revenue per share | 4.67 - | 5.67 21.41% | 7.81 37.76% | 10.30 31.90% | 13.45 30.57% | 17.13 27.40% | 18.61 8.64% | 18.78 0.88% | 22.70 20.92% | |
roe | 0.04 - | 0.39 793.02% | 0.10 73.47% | 0.12 11.45% | 0.16 41.11% | 0.28 69.95% | 0.19 31.08% | 0.17 10.98% | 0.09 46.46% | |
roic | 0.04 - | 0.39 810.80% | 0.10 73.72% | 0.11 4.43% | 0.16 49.19% | 0.23 47.17% | 0.17 25.86% | 0.13 25.49% | 0.18 37.99% | |
sales general and administrative to revenue | 0.58 - | 0.55 6.53% | 0.50 8.69% | 0.49 1.72% | 0.44 9.67% | 0.42 5.56% | ||||
shareholders equity per share | 4.28 - | 7.18 67.65% | 8.74 21.77% | 10.46 19.66% | 15.62 49.36% | 20.86 33.58% | 23.58 13.05% | 29.46 24.91% | 33.08 12.30% | |
stock based compensation to revenue | 0.06 - | 0.07 17.42% | 0.09 22.91% | 0.07 16.28% | 0.07 7.92% | 0.07 4.21% | 0.05 33.20% | 0.06 17.24% | 0.05 7.86% | |
tangible asset value | 130.36M - | 245.31M 88.18% | 320.38M 30.60% | 406.54M 26.90% | 637.01M 56.69% | 889.08M 39.57% | 1.01B 13.70% | 1.20B 19.06% | 1.38B 14.73% | |
tangible book value per share | 3.31 - | 6.04 82.17% | 7.59 25.73% | 9.40 23.86% | 14.43 53.44% | 19.80 37.22% | 22.38 13.03% | 26.66 19.17% | 30.39 13.96% | |
working capital | 87.56M - | 180.82M 106.52% | 241.85M 33.75% | 257.34M 6.40% | 409.59M 59.16% | 571.20M 39.46% | 503.98M 11.77% | 659.00M 30.76% | 838.02M 27.17% |
All numbers in (except ratios and percentages)